SFX by Ex Libris Inc.

Title:	Opioid Activity Profiles of Oversimplified Peptides Lacking in the Protonable N-Terminus
Source:	Journal of Medicinal Chemistry [0022-2623] yr:2012

Basic

Full text

Full text available via American Chemical Society Journals

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	De Marco, R. "Controlled Solid Phase Peptide Bond Formation UsingN-Carboxyanhydrides and PEG Resins in Water." ACS sustainable chemistry & engineering 1.6 (2013): 4294967295-569.
description	2.	Kumar, A. "Green solid-phase peptide synthesis 4. γ-Valerolactone and N -formylmorpholine as green solvents for solid phase peptide synthesis." Tetrahedron. 58.30: 2986-2988.
description	3.	Jad, Yahya E. "Green Solid-Phase Peptide Synthesis 2. 2-Methyltetrahydrofuran and Ethyl Acetate for Solid-Phase Peptide Synthesis under Green Conditions." ACS sustainable chemistry & engineering 4.12 (2016): 6809-6814.
description	4.	Artali, R. "The Inverse Type II β-Turn on D-Trp-Phe, a Pharmacophoric Motif for MOR Agonists." ChemMedChem 6.9 (2011): 1640-1653.
description	5.	Chen, S. "Bicyclic Peptide Ligands Pulled out of Cysteine-Rich Peptide Libraries." Journal of the American Chemical Society 135.17 (2013): 6562-6569.
description	6.	Marcus Baumann, M. "Azide monoliths as convenient flow reactors for efficient Curtius rearrangement reactions." Organic & biomolecular chemistry 6.9: 1587-1593.
description	7.	Angelini, A. "Bicyclic peptide inhibitor reveals large contact interface with a protease target." ACS chemical biology 7.5 (2012): 817-21.
description	8.	Baumann, M. "A modular flow reactor for performing Curtius rearrangements as a continuous flow process." Organic & biomolecular chemistry 6.9 (2008): 1577-1586.
description	9.	Magtaan, Jordan K. "Regeneration of aged DMF for use in solid-phase peptide synthesis." Journal of Peptide Science 25.1 (2019).
description	10.	Jaradat, J. "Thirteen decades of peptide synthesis: key developments in solid phase peptide synthesis and amide bond formation utilized in peptide ligation." Amino Acids 50.1 (2017): 39-68.
description	11.	Sawai, Y. "ChemInform Abstract: Green Processes for Peptide Mimetic Diabetic Drugs." Chem Inform 42.25 (2011).
description	12.	Lakshminarasimhan, R. "Down-regulation of ARID1A is sufficient to initiate neoplastic transformation along with epigenetic reprogramming in non-tumorigenic endometriotic cells." Cancer Letters 401 (2017): 11-19.
description	13.	Klein, Christian D. "Phenylglycine racemization in Fmoc-based solid-phase peptide synthesis: Stereochemical stability is achieved by choice of reaction conditions." Tetrahedron letters. 58.24: 2325-2329.
description	14.	Konwar, M. "A green protocol for peptide bond formation in WEB." Tetrahedron letters 57.21 (2016): 2283-2285.
description	15.	Jad, Yahya E. "Green Solid-Phase Peptide Synthesis (GSPPS) 3. Green Solvents for Fmoc Removal in Peptide Chemistry." Organic process research & development 21.3 (2017): 365-369.
description	16.	Prat, D. "A survey of solvent selection guides." Green chemistry 16.10 (2014): 4546-4551.
description	17.	Gentilucci, L. "Synthesis of Constrained Peptidomimetics Containing 2-Oxo-1,3-oxazolidine-4-carboxylic Acids." European journal of organic chemistry 2011.25 (2011): 4925-4930.
description	18.	Baeriswyl, V. "Bicyclic Peptides with Optimized Ring Size Inhibit Human Plasma Kallikrein and its Orthologues While Sparing Paralogous Proteases." ChemMedChem 7.7 (2012): 1173-1176.
description	19.	Osapay, G. "Chemical synthesis, recombinant expression, and antimicrobial properties of human beta-defensins." Biopolymers 80.4 (2005): 543-543.
description	20.	Lehmann, A. "Ecallantide (DX-88), a plasma kallikrein inhibitor for the treatment of hereditary angioedema and the prevention of blood loss in on-pump cardiothoracic surgery." Expert Opinion on Biological Therapy 8.8 (2008): 1187-1199.